BD to Present at Bank of America Securities Health Care Conference
BD (Becton, Dickinson and Company), a global leader in medical technology, has announced its upcoming participation in the Bank of America Securities Health Care Conference. The presentation is scheduled for Tuesday, May 13, 2025, at 1:00 pm Eastern Time.
Investors and interested parties can access the live webcast through the BD investor relations website at investors.bd.com. For those unable to attend the live presentation, a replay will be made available on the same platform after the event concludes.
BD (Becton, Dickinson and Company), leader mondiale nella tecnologia medica, ha annunciato la sua prossima partecipazione alla Bank of America Securities Health Care Conference. La presentazione è prevista per martedì 13 maggio 2025, alle ore 13:00 Eastern Time.
Investitori e soggetti interessati potranno seguire la diretta streaming tramite il sito web delle relazioni con gli investitori di BD all'indirizzo investors.bd.com. Per chi non potrà assistere alla presentazione in diretta, sarà disponibile una registrazione sulla stessa piattaforma al termine dell'evento.
BD (Becton, Dickinson and Company), líder mundial en tecnología médica, ha anunciado su próxima participación en la Bank of America Securities Health Care Conference. La presentación está programada para el martes 13 de mayo de 2025 a la 1:00 pm hora del Este.
Los inversores y partes interesadas pueden acceder a la transmisión en vivo a través del sitio web de relaciones con inversores de BD en investors.bd.com. Para quienes no puedan asistir a la presentación en vivo, se ofrecerá una repetición en la misma plataforma después de que finalice el evento.
BD (Becton, Dickinson and Company)는 의료 기술 분야의 글로벌 선두 기업으로, Bank of America Securities Health Care Conference에 곧 참여할 예정임을 발표했습니다. 발표는 2025년 5월 13일 화요일 동부 표준시 오후 1시에 예정되어 있습니다.
투자자 및 관심 있는 분들은 BD 투자자 관계 웹사이트인 investors.bd.com에서 라이브 웹캐스트를 시청할 수 있습니다. 라이브 발표에 참석하지 못하는 분들을 위해 행사가 끝난 후 동일한 플랫폼에서 다시보기가 제공될 예정입니다.
BD (Becton, Dickinson and Company), un leader mondial de la technologie médicale, a annoncé sa prochaine participation à la Bank of America Securities Health Care Conference. La présentation est prévue pour le mardi 13 mai 2025 à 13h00, heure de l'Est.
Les investisseurs et les parties intéressées peuvent accéder à la diffusion en direct via le site web des relations investisseurs de BD à l'adresse investors.bd.com. Pour ceux qui ne pourront pas assister à la présentation en direct, une rediffusion sera disponible sur la même plateforme après la fin de l'événement.
BD (Becton, Dickinson and Company), ein weltweit führendes Unternehmen im Bereich Medizintechnik, hat seine bevorstehende Teilnahme an der Bank of America Securities Health Care Conference angekündigt. Die Präsentation ist für Dienstag, den 13. Mai 2025, um 13:00 Uhr Eastern Time geplant.
Investoren und Interessierte können den Live-Webcast über die Investor-Relations-Website von BD unter investors.bd.com verfolgen. Für diejenigen, die nicht live teilnehmen können, wird eine Aufzeichnung im Anschluss an die Veranstaltung auf derselben Plattform verfügbar sein.
- BD's management participation in a major healthcare conference indicates strong investor relations and transparency
- None.
The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com. A replay of the event will be available on the same webpage following its conclusion.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.
Contacts: | |
Media: | Investors: |
Troy Kirkpatrick | Adam Reiffe |
VP, Public Relations | Sr. Director, Investor Relations |
858.617.2361 | 201.847.6927 |
View original content:https://www.prnewswire.com/news-releases/bd-to-present-at-bank-of-america-securities-health-care-conference-302443046.html
SOURCE BD (Becton, Dickinson and Company)